Onera Health

Onera Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $39M

Overview

Onera Health is a commercial-stage medical technology company focused on transforming sleep diagnostics. Its core product, the Onera Sleep Test System (STS), is a self-applied, wireless patch system that captures the full set of signals required for gold-standard polysomnography (PSG) at home or in a clinic. The company operates a PSG-as-a-service model, combining its FDA-cleared and CE-marked hardware with a cloud-based platform for data analysis and reporting. Onera targets the large and underserved market of sleep disorder diagnostics, offering a solution that improves patient comfort, accessibility, and clinical workflow efficiency.

Sleep DisordersSleep ApneaInsomniaNarcolepsy

Technology Platform

The Onera Sleep Test System (STS) is a patch-based, no-wire sensor system that captures the full polysomnography (PSG) signal set (EEG, EOG, EMG, ECG, respiratory effort, airflow, SpO2, position). It is paired with a cloud-based Digital Health Platform for data management, analysis, and reporting, enabling PSG studies to be conducted at home or in-clinic with minimal setup.

Funding History

2
Total raised:$39M
Series A$32M
Seed$7M

Opportunities

The massive, underserved global sleep disorder market and the strong trend toward decentralized, home-based care present a significant growth opportunity.
Onera's full-PSG-at-home solution can capture share from both the traditional sleep lab market and the simpler home sleep apnea test market by offering a more comprehensive and patient-friendly diagnostic.

Risk Factors

Key risks include slow adoption by clinicians and payers due to entrenched workflows and reimbursement challenges.
The company also faces competition from both established medical device companies and evolving consumer wearables, and must successfully manage the operational complexities of a hardware-plus-service model.

Competitive Landscape

Onera competes in the sleep diagnostics market against traditional in-lab PSG providers and companies offering simpler Type III home sleep apnea tests (HSAT) like ResMed and Philips. Its primary differentiation is offering a full, no-wire PSG for use at home. It also faces potential long-term competition from advanced consumer wearables, though these lack clinical validation for diagnostic use.